Ongoing innovations in mice models, continuous support in the form of investments and grants, and growing demand for humanized mice models are some of the factors driving the growth of the mice model market. The mice model market is expanding with the increase in R&D activities in pharmaceutical industries. These mice model are being used in many applications such as oncology studies, immunology and inflammation studies, central nervous system studies (anxiety and other disorders), cardiovascular studies, diabetes studies. The base year considered for the study is 2015, and the forecast has been provided for the period between 2016 and 2021.
The overall mice model market is expected to grow from USD 1.11 billion in 2016 to USD 1.59 billion by 2021, at a CAGR of 7.5% from 2016 to 2021.
Market Dynamics
+ Drivers
+ Ongoing innovations in mice models
+ Growing consumption of personalized medicine driving the demand for humanized mice models
+ Continuous support in the form of grants and investments
Download Free PDF BROCHURE - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1308
Growing consumption of personalized medicine designed through the use of mice model, drives the global mice model market.
Personalized medicine is the process of developing tailored medications to target individualized treatment and care based on personal and genetic variation. These medicines are designed through the use of animal models, particularly mice models. In this process, immune-deficient models are transplanted with human tissues and the disease expressed is recorded. This is followed by treating the model with a whole series of drugs or gene therapies to find the most suitable treatment, thus generating suitable or personalized medicines for patients.
Mice model applications in various therapeutic indications such as immunology and inflammation studies, central nervous system studies (anxiety and other disorders), cardiovascular studies, diabetes studies, and other disease studies (mice models for rare diseases and metabolism & regulatory disorder studies, hematopoiesis, renal and toxicology studies) coupled with the ongoing innovations in mice models drive the growth of mice model market.
View Complete Press Releases - https://www.marketsandmarkets.com/PressReleases/mice-model.asp
Ongoing innovations in mice models, continuous support in the form of investments and grants, and growing demand for humanized mice models are some of the factors driving the growth of the mice model market.
The mice model market is expanding with the increase in R activities in pharmaceutical industries.
These mice model are being used in many applications such as oncology studies, immunology and inflammation studies, central nervous system studies (anxiety and other disorders), cardiovascular studies, diabetes studies.
The base year considered for the study is 2015, and the forecast has been provided for the period between 2016 and 2021.The overall mice model market is expected to grow from USD 1.11 billion in 2016 to USD 1.59 billion by 2021, at a CAGR of 7.5% from 2016 to 2021.Market Dynamics+ Drivers+ Ongoing innovations in mice models+ Growing consumption of personalized medicine driving the demand for humanized mice models+ Continuous support in the form of grants and investmentsDownload Free PDF BROCHURE - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1308Growing consumption of personalized medicine designed through the use of mice model, drives the global mice model market.Personalized medicine is the process of developing tailored medications to target individualized treatment and care based on personal and genetic variation.
These medicines are designed through the use of animal models, particularly mice models.
In this process, immune-deficient models are transplanted with human tissues and the disease expressed is recorded.
Global Humanized Mice Model Market: OverviewThe healthcare industry, despite facing vast political and economic uncertainty in the past few years, continues to remain dynamic when it comes to funds being diverted to the R sector and the introduction of novel and technologically advanced medical devices, medical imaging equipment, and pharmaceutical and biopharmaceutical products.
Attempts to engraft mouse bone marrow with human hematopoietic stem cells and mouse liver with human hepatocytes, allowing them to overcome the limitations of the conventional xenograft models, has also provided new opportunities to the market.
Global Humanized Mice Model Market: Trends and OpportunitiesThe rising demand from the healthcare sector for more effective screening of new drug candidates discovered to treat a variety of chronic diseases such as cardiovascular conditions, diabetes, and cancers, has remained one of the leading factors driving increased research activities in the field of humanized mice models.
The consecutive rise in competition has also compelled companies to focus more on R activities aimed at the development of more reliable mice models that can improve the outcomes of research studies.Request COVID Analysis on Humanized Mice Model Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19_id=49656Moreover, the market benefits from the fact that humanized mice models are better research tools as compared to mutant mouse protein.
Humanized mice models are considered more realistic for studying tumors as compared to cultured cancer cells and also find usage for evaluating the safety of certain biologics when neither rats nor normal mice are useful.
The key end users of humanized mice models examined in the report include contract research organization, pharmaceutical and biotechnology companies, and academic and research institutions.
